Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism

被引:28
|
作者
Groeger, S. [1 ]
Denter, F. [1 ]
Lochnit, G. [2 ,3 ,4 ]
Schmitz, M. L. [2 ,3 ,4 ]
Meyle, J. [1 ]
机构
[1] Justus Liebig Univ Giessen, Dept Periodontol, Giessen, Germany
[2] Inst Biochem, Giessen, Germany
[3] German Ctr Lung Res, Giessen, Germany
[4] Justus Liebig Univ, Giessen, Germany
关键词
PD-L1; B7-H1; Porphyromonas gingivalis; immune evasion; immune suppression; signaling pathway; GASTRIC EPITHELIAL-CELLS; OUTER-MEMBRANE; B7-DC RECEPTORS; T-CELLS; B7-H1; NOD1; INNATE; PEPTIDOGLYCAN; SURAMIN; FAMILY;
D O I
10.1128/IAI.00051-20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed death-ligand 1 (PD-L1/B7-H1) serves as a cosignaling molecule in cell-mediated immune responses and contributes to chronicity of inflammation and the escape of tumor cells from immunosurveillance. Here, we investigated the molecular mechanisms leading to PD-L1 upregulation in human oral carcinoma cells and in primary human gingival keratinocytes in response to infection with Porphyromonas gingivalis (P. gingivalis), a keystone pathogen for the development of periodontitis. The bacterial cell wall component peptidoglycan uses bacterial outer membrane vesicles to be taken up by cells. Internalized peptidoglycan triggers cytosolic receptors to induce PD-L1 expression in a myeloid differentiation primary response 88 (Myd88)-independent and receptor-interacting serine/threonine-protein kinase 2 (RIP2)-dependent fashion. Interference with the kinase activity of RIP2 or mitogen-activated protein (MAP) kinases interferes with inducible PD-L1 expression.
引用
收藏
页数:13
相关论文
共 45 条
  • [31] Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
    Ahrong Kim
    So Jeong Lee
    Young Keum Kim
    Won Young Park
    Do Youn Park
    Jee Yeon Kim
    Chang Hun Lee
    Gyungyub Gong
    Gi Yeong Huh
    Kyung Un Choi
    Scientific Reports, 7
  • [32] EXPRESSION OF PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) IN MENINGIOMA: CLINICAL UTILITY FOR PREDICTION OF TUMOR RECURRENCE AND ASSOCIATION WITH HYPOXIC RESPONSE AND NFKB2 ACTIVATION
    Karimi, Shirin
    Suppiah, Suganth
    Mansouri, Sheila
    Nassiri, Farshad
    Mamatjan, Yasin
    Liu, Jeff
    Aldape, Kenneth
    Zadeh, Gelareh
    NEURO-ONCOLOGY, 2018, 20 : 150 - 151
  • [33] Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
    Kim, Ahrong
    Lee, So Jeong
    Kim, Young Keum
    Park, Won Young
    Park, Do Youn
    Kim, Jee Yeon
    Lee, Chang Hun
    Gong, Gyungyub
    Huh, Gi Yeong
    Choi, Kyung Un
    SCIENTIFIC REPORTS, 2017, 7
  • [34] Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients with Chest Wall Breast Cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1)
    Valenza, Carmine
    Giachetti, Pier Paolo Maria Berton
    Zagami, Paola
    Nicolo, Eleonora
    Trapani, Dario
    Boldrini, Laura
    Salimbeni, Beatrice Taurelli
    Ascione, Liliana
    Antonarelli, Gabriele
    Corti, Chiara
    Esposito, Angela
    Criscitiello, Carmen
    Fusco, Nicola
    Curigliano, Giuseppe
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Pneumococal Surface Protein A (PspA) Regulates Programmed Death Ligand 1 Expression on Dendritic Cells in a Toll-Like Receptor 2 and Calcium Dependent Manner
    Vashishta, Mohit
    Khan, Naeem
    Mehto, Subhash
    Sehgal, Devinder
    Natarajan, Krishnamurthy
    PLOS ONE, 2015, 10 (07):
  • [36] Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer
    Lv, Huifang
    Zhang, Junling
    Sun, Keran
    Nie, Caiyun
    Chen, Beibei
    Wang, Jianzheng
    Xu, Weifeng
    Wang, Saiqi
    Liu, Yingjun
    Chen, Xiaobing
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [37] Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines
    Stanciu, LA
    Bellettato, CM
    Laza-Stanca, V
    Coyle, AJ
    Papi, A
    Johnston, SL
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (03): : 404 - 412
  • [38] Co-inhibition of adenosine 2b receptor and programmed death-ligand 1 promotes the recruitment and cytotoxicity of natural killer cells in oral squamous cell carcinoma
    Wang, Bing
    Wang, Tao
    Yang, Chengzhe
    Nan, Zhaodi
    Ai, Dan
    Wang, Xin
    Wang, Huayang
    Qu, Xun
    Wei, Fengcai
    PEERJ, 2023, 11
  • [39] Programmed cell death receptor ligand 1 (PD-L1) expression: Epidermal growth factor receptor (EGFR) and Kirsten RAS (KRAS) mutations in second-line therapy (2L) non-small cell lung cancer (NSCLC) patients-A Danish cohort study.
    Cronin-Fenton, Deirdre
    Dalvi, Tapashi
    Hedgeman, Elizabeth
    Norgaard, Mette
    Pedersen, Lars
    Hansen, Hanh
    Fryzek, Jon
    Lawrence, David
    Walker, Jill
    Mellemgaard, Anders
    Rasmussen, Torben Riis
    Shire, Norah
    Rigas, James R.
    Potter, Danielle
    Hamilton, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer (vol 10, 580045, 2021)
    Lv, Huifang
    Zhang, Junling
    Sun, Keran
    Nie, Caiyun
    Chen, Beibei
    Wang, Jianzheng
    Xu, Weifeng
    Wang, Saiqi
    Liu, Yingjun
    Chen, Xiaobing
    FRONTIERS IN ONCOLOGY, 2021, 11